Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains

This article was originally published in PharmAsia News

Executive Summary

FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain

You may also be interested in...

What’s In A PDUFA Reauthorization? Maybe These Issues…

FDA Will Have Risk-Based Import Screening System Up And Running Throughout U.S. By Year's End

Limited roll out of the PREDICT system shows it has been effective in identifying the riskier imports that should be the focus of inspectors' attention, Commissioner Hamburg tells House panel

FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan

Agency wants to target supply-chain threats and help judge the value of information received from third-party inspections.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts